Cargando…
Indoxyl Sulfate Might Play a Role in Sarcopenia, While Myostatin Is an Indicator of Muscle Mass in Patients with Chronic Kidney Disease: Analysis from the RECOVERY Study
Serum myostatin and indoxyl sulfate (IS) levels increase with kidney function decline and may function as uremic toxins in chronic kidney disease (CKD)-related sarcopenia. Herein, we analyzed the association between serum myostatin and IS levels and sarcopenia in patients with CKD, by performing a p...
Autores principales: | Lee, Su Mi, Han, Mi Yeun, Kim, Su Hyun, Cha, Ran Hui, Kang, Seock Hui, Kim, Jun Chul, An, Won Suk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610577/ https://www.ncbi.nlm.nih.gov/pubmed/36287929 http://dx.doi.org/10.3390/toxins14100660 |
Ejemplares similares
-
Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1
por: Enoki, Yuki, et al.
Publicado: (2016) -
Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease
por: Sato, Emiko, et al.
Publicado: (2016) -
Effects of AST‐120 on muscle health and quality of life in chronic kidney disease patients: results of RECOVERY study
por: Cha, Ran‐hui, et al.
Publicado: (2021) -
Indoxyl Sulfate, a Uremic Endotheliotoxin
por: Lano, Guillaume, et al.
Publicado: (2020) -
Indoxyl sulfate promotes apoptosis in cultured osteoblast cells
por: Kim, Young-Hee, et al.
Publicado: (2013)